FDA Approves Monjuvi With Revlimid and Rituxan for Follicular Lymphoma
The FDA approved Monjuvi with Revlimid and Rituxan for R/R follicular lymphoma after it showed significantly longer progression-free survival vs placebo.
The FDA approved Monjuvi with Revlimid and Rituxan for R/R follicular lymphoma after it showed significantly longer progression-free survival vs placebo.
Celebrate the individuals making an extraordinary impact on the blood cancer community. From healthcare professionals and advocates to patients and caregivers, we’re honoring those who…
Read about the nurse with over four decades of experience who has been appointed as temporary chief executive of NHS Golden Jubilee.
Immunotherapy for the treatment of ALL: What you need to know
Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood and addressed throughout cancer care.
The NHS Staff Survey will, for the first time in 2025, have ‘Filipino’ as a distinct ethnicity option. Read more.
Members of the Royal College of Nursing in England, Wales and Northern Ireland have overwhelmingly rejected the most recent NHS pay offer.
The Nursing Times Workforce Summit & Awards is a collaborative effort with the sector, bringing together expertise in workforce planning and real-world case studies. Its…
Shonna Spreadbury on how increasing technology within the clinician’s role must benefit their ways of working.
The Queen’s Institute of Community Nursing has announced two promotions within its senior management team, including a new deputy chief exec.
Background Virtual scholarly events play an increasing role in doctoral education, particularly in nursing. The PhD Virtual Connect-event has been held annually for the past…